TRAVEL NURSING NEWS
A collection of nursing news for the ultimate travel nurse!

Article Date: 07/14/2009

Taking Action on Darvon and Other Pain Medications
On July 7, 2009, the Food and Drug Administration (FDA) announced actions it was taking to reduce the risk of overdose in people who use pain medications, such as Darvon and Darvocet. These medications contain the drug propoxyphene, which is linked to death from overdoses.

FDA finds there is evidence that propoxyphene can effectively treat pain at recommended doses. But because of the drug’s potential risks, the agency is requiring manufacturers to provide more information to help physicians and patients decide whether propoxyphene is the appropriate pain treatment.

As a result, the FDA is requiring manufacturers of propoxyphene-containing products to: (1) strengthen the label’s boxed warning to emphasize the risk for overdose when using these products, and (2) provide a medication guide (FDA-approved information that must be given to patients with each prescription or refill) to stress the importance of using the pain drugs only as directed.

A new safety study is needed to find out more about the effects of propoxyphene on the heart at higher than recommended doses. FDA is planning to work with other federal agencies, such as the Centers for Medicare and Medicaid Services and the Department of Veterans Affairs, to conduct additional studies on the safety of products that contain propoxyphene as compared to other commonly used pain medications. The FDA has denied a citizen petition from the public interest group Public Citizen requesting a phased withdrawal of propoxyphene. The safety of propoxyphene will be further be evaluated and additional regulatory action will be taken, if necessary.

Propoxyphene has been on the market since 1957. It is a widely prescribed medication in a group of drugs known as opioids, and is used to treat mild to moderate pain.
The most frequent side effects of propoxyphene include lightheadedness, dizziness, sedation, nausea, and vomiting. Consumers should be aware of all the risks associated with pain medication, including propoxyphene, when making decisions on how to treat pain. All pain medicines have side effects.

Please talk to your health care professional to decide on the appropriate pain treatment for you if you need relief from pain.

Website Address: http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm171714.htm

MORE NURSING NEWS ARTICLES



Web SSP
Lising of US Hospitals
Continental Nurses - Travel Nursing Agency
Nursing Continuing Education
Mooresville Healthcare - Healthcare in Mooresville NC
Continental Allied - Allied Health Care Jobs
Housing for Travel Nurses
SSMC - Supplemental Staffing Management Corporation
Travel Nursing Headquarters
New York Allied Health Care Jobs

Nurses are Key to Healthcare Reform
TRAVEL NURSING NEWS
Read all the news you want here at Travel Nursing News!
Travel Nursing news gives you one source to find all the nursing news on-line.

Copyright© 2010, Travel Nursing News. All rights reserved.